1.
|
Phase: Phase III, Phase II Type: Prevention Status: Closed Age: 45 to 75 Sponsor: NCI, Other Protocol IDs: 5 R01 CA098286-03, NCT00153816
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Closed Age: premenopausal Sponsor: Other Protocol IDs: DFCI-92044, NCI-V96-0801
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NOVARTIS-4244603039
|
|
4.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 40 and over Sponsor: NCI Protocol IDs: CALGB-79809, NCI-P01-0184, NCT00022087
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
|
|
6.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: CBCG-4400
|
|
7.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N02C1, N02C1, NCT00054418
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NU-02U1, NCT00058188
|
|
9.
|
Phase: Phase III Type: Supportive care Status: Closed Age: Not specified Sponsor: Other Protocol IDs: BONEII, NCT00186901
|
|
10.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0518, 0518, NCT00329797
|
|
11.
|
Phase: Phase III Type: Natural history/Epidemiology, Supportive care Status: Closed Age: 45 and over Sponsor: NCI Protocol IDs: CAN-NCIC-MA27B, NCIC-MA.27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, NCT00354302, MA27B
|
|
12.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: IOWA-V87-0191, NCI-V87-0191
|
|
13.
|
Phase: Phase II Type: Prevention Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
|
|
14.
|
Phase: Phase II Type: Prevention Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CPMC-IRB-94087, NCI-P97-0111
|
|
15.
|
Phase: Phase II Type: Treatment Status: Closed Age: 15 and older Sponsor: Protocol IDs: UCMC-INT-0056, INT-0056
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: Any age Sponsor: NCI Protocol IDs: CCCWFU-29203, CCCWFU-BG03-117, NCT00068276
|
|
17.
|
Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: Other Protocol IDs: ONCO-09-99S, NCT00018538
|
|
18.
|
Phase: Phase II Type: Treatment Status: Closed Age: Any age Sponsor: NCI Protocol IDs: CCCWFU-29304, CCCWFU-BG04-452, NCT00104806
|
|
19.
|
Phase: Phase II Type: Prevention Status: Closed Age: 30 to 74 Sponsor: NCI, Other Protocol IDs: 0126-2004, 5 R01 CA104637-02, NCT00208793
|
|
20.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Closed Age: postmenopausal Sponsor: Protocol IDs: CBCG-4401
|
|
21.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-4472, SEG-343
|
|
22.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-78706, NCT00470353
|
|
23.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-99207, I 99207, NCT00550563
|